Leukoaraiosis Predicts a Poor 90-Day Outcome after Endovascular Stroke Therapy

References

1. 1.↵
   2. Jauch EC,
   3. Saver JL,
   4. Adams HP Jr., et al

   . Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013;44:870–947

   Abstract/FREE Full Text
2. 2.↵
   2. Nogueira RG,
   3. Gupta R,
   4. Davalos A

   . IMS-III and SYNTHESIS expansion trials of endovascular therapy in acute ischemic stroke: how can we improve? Stroke 2013;44:3272–74

   FREE Full Text
3. 3.↵
   2. Broderick JP,
   3. Palesch YY,
   4. Demchuk AM, et al

   . Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013;368:893–903

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Shi ZS,
   3. Loh Y,
   4. Liebeskind DS, et al

   . Leukoaraiosis predicts parenchymal hematoma after mechanical thrombectomy in acute ischemic stroke. Stroke 2012;43:1806–11

   Abstract/FREE Full Text
5. 5.↵
   2. Jung S,
   3. Mono ML,
   4. Findling O, et al

   . White matter lesions and intra-arterial thrombolysis. J Neurol 2012;259:1331–36

   CrossRefPubMed
6. 6.↵
   2. Simoni M,
   3. Li L,
   4. Paul NL, et al

   . Age- and sex-specific rates of leukoaraiosis in TIA and stroke patients: population-based study. Neurology 2012;79:1215–22

   CrossRef
7. 7.↵
   2. Pantoni L

   . Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010;9:689–701

   CrossRefPubMedWeb of Science
8. 8.↵
   2. Henninger N,
   3. Lin E,
   4. Baker SP, et al

   . Leukoaraiosis predicts poor 90-day outcome after acute large cerebral artery occlusion. Cerebrovasc Dis 2012;33:525–31

   CrossRefPubMed
9. 9.↵
   United Nations Department of Economic and Social Affairs, Population Division. World Population Prospects. The 2006 Revision, Highlights, Working Paper No. ESA/P/WP. 202. Published 2007. http://www.un.org/esa/population/publications/wpp2006/WPP2006_Highlights_rev.pdf. Accessed May 12, 2014.
10. 10.↵
    2. Lozano R,
    3. Naghavi M,
    4. Foreman K, et al

    . Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2095–128

    CrossRefPubMedWeb of Science
11. 11.↵
    2. Murray CJ,
    3. Vos T,
    4. Lozano R, et al

    . Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2197–223

    CrossRefPubMed
12. 12.↵
    2. Duffis EJ,
    3. He W,
    4. Prestigiacomo CJ, et al

    . Endovascular treatment for acute ischemic stroke in octogenarians compared with younger patients: a meta-analysis. Int J Stroke 2014;9:308–12

    CrossRefPubMed
13. 13.↵
    2. Henninger N,
    3. Lin E,
    4. Haussen DC, et al

    . Leukoaraiosis and sex predict the hyperacute ischemic core volume. Stroke 2013;44:61–67

    Abstract/FREE Full Text
14. 14.↵
    2. Wardlaw JM,
    3. Smith EE,
    4. Biessels GJ, et al

    . Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013;12:822–38

    CrossRefPubMedWeb of Science
15. 15.↵
    2. Henninger N,
    3. Khan MA,
    4. Zhang J, et al

    . Leukoaraiosis predicts cortical infarct volume after distal middle cerebral artery occlusion. Stroke 2014;45:689–95

    Abstract/FREE Full Text
16. 16.↵
    2. Hacke W,
    3. Kaste M,
    4. Fieschi C, et al

    . Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017–25

    CrossRefPubMedWeb of Science
17. 17.↵
    2. Higashida RT,
    3. Furlan AJ,
    4. Roberts H, et al

    . Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 2003;34:e109–37

    Abstract/FREE Full Text
18. 18.↵
    2. Arsava EM,
    3. Rahman R,
    4. Rosand J, et al

    . Severity of leukoaraiosis correlates with clinical outcome after ischemic stroke. Neurology 2009;72:1403–10

    CrossRef
19. 19.↵
    2. Nogueira RG,
    3. Gupta R,
    4. Jovin TG, et al

    . Predictors and clinical relevance of hemorrhagic transformation after endovascular therapy for anterior circulation large vessel occlusion strokes: a multicenter retrospective analysis of 1122 patients. J Neurointerv Surg 2014 Jan 8. [Epub ahead of print]
20. 20.↵
    2. O'Sullivan M,
    3. Lythgoe DJ,
    4. Pereira AC, et al

    . Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis. Neurology 2002;59:321–26

    CrossRef
21. 21.↵
    2. Zaidi SF,
    3. Aghaebrahim A,
    4. Urra X, et al

    . Final infarct volume is a stronger predictor of outcome than recanalization in patients with proximal middle cerebral artery occlusion treated with endovascular therapy. Stroke 2012;43:3238–44

    Abstract/FREE Full Text
22. 22.↵
    2. Ay H,
    3. Arsava EM,
    4. Rosand J, et al

    . Severity of leukoaraiosis and susceptibility to infarct growth in acute stroke. Stroke 2008;39:1409–13

    Abstract/FREE Full Text
23. 23.↵
    2. Rüber T,
    3. Schlaug G,
    4. Lindenberg R

    . Compensatory role of the cortico-rubro-spinal tract in motor recovery after stroke. Neurology 2012;79:515–22

    CrossRef
24. 24.↵
    2. Borich MR,
    3. Mang C,
    4. Boyd LA

    . Both projection and commissural pathways are disrupted in individuals with chronic stroke: investigating microstructural white matter correlates of motor recovery. BMC Neurosci 2012;13:107

    CrossRefPubMed
25. 25.↵
    2. Held V,
    3. Szabo K,
    4. Bazner H, et al

    . Chronic small vessel disease affects clinical outcome in patients with acute striatocapsular stroke. Cerebrovasc Dis 2012;33:86–91

    CrossRefPubMed
26. 26.↵
    2. Koton S,
    3. Schwammenthal Y,
    4. Merzeliak O, et al

    . Cerebral leukoaraiosis in patients with stroke or TIA: clinical correlates and 1-year outcome. Eur J Neurol 2009;16:218–25

    CrossRefPubMed
27. 27.↵
    2. Kang HJ,
    3. Stewart R,
    4. Park MS, et al

    . White matter hyperintensities and functional outcomes at 2 weeks and 1 year after stroke. Cerebrovasc Dis 2013;35:138–45

    CrossRefPubMed
28. 28.
    2. van Swieten JC,
    3. Hijdra A,
    4. Koudstaal PJ, et al

    . Grading white matter lesions on CT and MRI: a simple scale. J Neurol Neurosurg Psychiatry 1990;53:1080–83

    Abstract/FREE Full Text